Fennec Pharmaceuticals Inc (FENC) Insider Trading
- $7,299,977.50
- $12,865,541.61
- Dec. 5, 2024
- Rosty Raykov
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Dec. 5, 2024 | Director | 796 | $6.04 | Sell | $4,807.84 | |
| Dec. 2, 2024 | Director | 6,409 | $6.14 | Sell | $39,351.26 | |
| Nov. 4, 2024 | Director | 2,431 | $4.31 | Sell | $10,477.61 | |
| Oct. 8, 2024 | Director | 1,406 | $4.53 | Sell | $6,369.18 | |
| Oct. 1, 2024 | Director | 2,431 | $4.94 | Sell | $12,009.14 | |
| Aug. 1, 2024 | CEO | 2,431 | $6.25 | Sell | $15,193.75 | |
| July 5, 2024 | Director | 1,173 | $6.03 | Sell | $7,073.19 | |
| July 2, 2024 | CEO | 2,431 | $6.13 | Sell | $14,902.03 | |
| June 3, 2024 | CEO | 2,431 | $6.76 | Sell | $16,433.56 | |
| May 1, 2024 | CEO | 2,431 | $9.11 | Sell | $22,146.41 | |
| April 22, 2024 | COO | 22,223 | $9.32 | Sell | $207,118.36 | |
| April 19, 2024 | COO | 22,222 | $9.34 | Sell | $207,553.48 | |
| April 17, 2024 | COO | 22,222 | $9.91 | Sell | $220,220.02 | |
| April 15, 2024 | Director | 800 | $10.45 | Sell | $8,360.00 | |
| April 15, 2024 | COO | 22,222 | $10.30 | Sell | $228,886.60 | |
| April 5, 2024 | CEO | 44,300 | $10.75 | Sell | $476,225.00 | |
| April 3, 2024 | CEO | 40,584 | $10.78 | Sell | $437,495.52 | |
| March 26, 2024 | Director | 2,114 | $10.97 | Sell | $23,190.58 | |
| March 25, 2024 | CFO | 13,975 | $11.00 | Sell | $153,725.00 | |
| Jan. 4, 2024 | CFO | 15,000 | $10.64 | Sell | $159,600.00 | |
| Dec. 28, 2023 | CEO | 3,656 | $11.55 | Sell | $42,226.80 | |
| Dec. 26, 2023 | Director | 1,390 | $10.90 | Sell | $15,151.00 | |
| Nov. 20, 2023 | Director | 269 | $8.25 | Sell | $2,219.25 | |
| Nov. 8, 2023 | CEO | 25,044 | $7.76 | Sell | $194,341.44 | |
| Aug. 18, 2023 | Director | 673 | $7.85 | Sell | $5,283.05 | |
| July 24, 2023 | Director | 6,796 | $8.17 | Sell | $55,523.32 | |
| July 6, 2023 | Director | 2,207 | $8.47 | Sell | $18,693.29 | |
| June 30, 2023 | CFO | 7,500 | $8.82 | Sell | $66,150.00 | |
| June 28, 2023 | CFO | 10,000 | $8.99 | Sell | $89,900.00 | |
| May 19, 2023 | Director | 1,758 | $7.36 | Sell | $12,938.88 | |
| Dec. 30, 2022 | CFO | 5,500 | $9.61 | Sell | $52,855.00 | |
| Dec. 30, 2022 | CEO | 10,000 | $9.62 | Sell | $96,200.00 | |
| Dec. 28, 2022 | CFO | 11,000 | $9.61 | Sell | $105,710.00 | |
| Dec. 28, 2022 | CEO | 13,740 | $9.59 | Sell | $131,766.60 | |
| April 30, 2020 | Major Shareholder | 768,000 | $6.25 | Buy | $4,800,000.00 | |
| March 28, 2018 | Major Shareholder | 914,745 | $10.61 | Sell | $9,705,444.45 | |
| Dec. 12, 2017 | Major Shareholder | 294,115 | $8.50 | Buy | $2,499,977.50 |
Insiders are both buying and selling Fennec Pharmaceuticals Inc stock.
The insider traders at Fennec Pharmaceuticals Inc are: Rosty Raykov, Chris A Rallis, Robert Andrade, Adrian Haigh, Spa Essetifin, and Manchester Management Pr, Llc
The most active insider trader at Fennec Pharmaceuticals Inc is Rosty Raykov with 13 trades.
Manchester Management Pr, Llc has sold the most Fennec Pharmaceuticals Inc stock with a total value of $19,410,888.90.
Spa Essetifin has bought the most Fennec Pharmaceuticals Inc stock with a total value of $12,099,977.50.
The most recent insider trade for Fennec Pharmaceuticals Inc was on Dec. 5, 2024.
The single biggest insider buy for Fennec Pharmaceuticals Inc was from Spa Essetifin with a total value of $4,800,000.00 on April 30, 2020.
The single biggest insider sell for Fennec Pharmaceuticals Inc was from Manchester Management Pr, Llc with a total value of $9,705,444.45 on March 28, 2018.